WithdrawnPHASE1, PHASE2NCT01647152

Ustekinumab for Active Sight-Threatening Uveitis

Studying Uveitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Eye Institute (NEI)
Principal Investigator
Hatice N Sen, M.D.
National Eye Institute (NEI)
Intervention
Ustekinumab(drug)
Eligibility
18 years · All sexes
Timeline
20122015

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01647152 on ClinicalTrials.gov

Other trials for Uveitis

Additional recruiting or active studies for the same condition.

See all trials for Uveitis

← Back to all trials